1 1 9 1 r e s o u r c e High-resolution mass spectrometry (MS) has become the primary analysis tool for many classes of biomolecules, including proteins, metabolites, and lipids. Major advancements in MS technologyparticularly in the rate and depth of analysis-have enabled dozens of proteomes, metabolomes, and lipidomes to be analyzed in a single day [1] [2] [3] . Studies of bacteria demonstrated that parallel measurement of multiple molecule classes can synergistically enhance the biological insight afforded 4,5 . Recently, proteomics has been integrated with transcriptomics and genomics in mice 6,7 . However, large-scale, comprehensive (i.e., proteome-wide), multi-omic data acquisition, integration, and visualization tools remain underdeveloped, often lagging behind genomics in terms of coverage, speed, and broad accessibility for end users. Given the interdependence of proteins, lipids, and metabolites, we reasoned that coordinated analysis across all three biomolecule classes could afford new insight into eukaryotic biology. In particular, we hypothesized that this multi-omic profiling strategy, when coupled with genetic and environmental perturbations, could enable functional predictions for uncharacterized proteins.
r e s o u r c e
In selecting these targets, we prioritized genes with human homologs (144/174 genes) and those associated with disease (60/144 genes) as determined by primary literature analysis and online database gene annotation (e.g., http://omim.org/). Inclusion of characterized genes, some of which could be considered as only partially characterized, also provided the ability to connect them to previously unrecognized functions. Each strain was grown in biological triplicate under two contrasting growth conditions, a standard fermentation culture condition and a carefully optimized respiration culture condition that stimulated mitochondrial function ( Fig. 1a, Supplementary  Fig. 1b -e, and Supplementary Note 1)-yielding six separate cultures per yeast strain.
Altogether we grew more than 1,050 yeast cultures (including wildtype (WT) cultures), each of which was analyzed using three separate high-resolution MS-based proteomic, metabolomic, and lipidomic techniques. These more than 3,000 MS experiments yielded quantitation of 4,040 proteins, 411 metabolites, and 53 lipids (averaging 3,180 proteins, 252 metabolites, and 53 lipids per culture) ( Supplementary  Table 2 )-over 3.5 million biomolecule measurements in total ( Fig. 1a,  Supplementary Fig. 2a,b, and Supplementary Table 3 ). Key to our approach was streamlining procedures for proteome extraction and preparation to under 2 h of hands-on time (Supplementary Fig. 2c ). Use of label-free quantitation negated the need for a chemical tagging step and further increased throughput. We observed a wide dynamic range across all profiled omes, with some molecule abundances spanning more than three orders of magnitude ( Supplementary Fig. 2d) . Additionally, we observed remarkable reproducibility between replicate cultures, with a median coefficient of variation of 12.7% considering all profiled biomolecules, and high overlap of molecules quantified across cultures (Supplementary Fig. 2e-g) .
A high-level view of the Y3K data set showed significant (P < 0.05) perturbations across all three omes, with more pronounced perturbations in respiration ( Fig. 1b and Supplementary Fig. 3a) . Hierarchical clustering revealed groups of functionally related molecules (along the y axis) and groups of functionally related ∆gene strains (along the x axis). Protein clusters showed significant (P < 0.05) gene ontology (GO) term enrichments for diverse processes and included both characterized and uncharacterized proteins ( Supplementary Fig. 3b ). For example, the uncharacterized proteins Esbp6p and Ypr010c-a cluster with proteins involved in mitochondrial ATP synthesis and electron transport chain function, respectively (Supplementary Fig. 4 ). We leveraged analyses from three different vantage points, each of which can be recapitulated with our online data visualization suite, exploiting unique biological perspectives afforded by a multi-omic data set of diverse genetic perturbations ( Fig. 1c and Supplementary Code) .
Identification of gene-specific phenotypes
First, we systematically surveyed the Y3K data set for significant (P < 0.05) molecule perturbations unique to just one or two of the strains in the study (Fig. 2a) . This unbiased search revealed 714 ∆gene-specific phenotypes ( Fig. 2a, Supplementary Table 4 , and Supplementary Note 2), which can reveal functional relationships. For example, the electron transfer flavoprotein (ETF) subunit Aim45p was uniquely decreased in just two ∆gene strains: the ∆aim45 strain, and the ∆cir1 strain, which lacks the second ETF heterodimer subunit ( Fig. 2b) . Numerous additional ∆gene-specific phenotypes were used to generate biological hypotheses ( Supplementary Figs. 5 and 6) . We decided to investigate one of these observations at biochemical depth: a ∆hfd1-specific decrease in 4-hydroxybenzoate (4-HB), the CoQ head-group precursor (Fig. 2c) .
Though it has been known for decades that mammals can convert tyrosine (Tyr) into 4-HB for CoQ biosynthesis 19, 20 , the biochemical pathway has remained undefined in mammals and yeast (Fig. 2c) . The Y3K data set reveals ∆hfd1 yeast to be significantly deficient in both the metabolite 4-HB (P < 0.001) and the lipid CoQ intermediate 3-polyprenyl-4-hydroxybenzoate (PPHB) (P < 10 −5 ) ( Fig. 2c and Supplementary Fig. 7a ). Despite the PPHB deficiency, ∆hfd1 yeast had normal CoQ abundance ( Fig. 2c) , likely because of increased Gene-gene correlations through molecular ngerprinting ( Fig. 3) Molecule covariance network analysis (MCNA) ( Fig. 4) Systematic identi cation of gene-speci c phenotypes ( Fig. 2) Open access at y3kproject.org Figure 1 Multi-omic MS profiling and data visualization. (a-c) Overviews of the experimental design and high-resolution quantitative MS analysis (a), the Y3K data set (b), shown as hierarchical clusters of ∆gene strains and significantly perturbed molecules (relative abundances compared to WT as quantified by MS, mean, n = 3; P < 0.05, two-sided Student's t-test), and the multi-omic data analysis and visualization tools developed here (c). r e s o u r c e flux through an alternative para-amino-benzoate (pABA)-dependent CoQ pathway 21, 22 , as suggested by elevation of the aminated analog of PPHB (PPAB) in ∆hfd1 yeast (Fig. 2c) . This is in contrast to terminal CoQ biosynthesis genes (coq3-coq9), and some genes not previously linked to CoQ function (e.g., oct1 and fzo1), whose deletion caused significant (P < 0.05) CoQ deficiency and accumulation of PPHB ( Fig. 2c) . Because Hfd1p is predicted to be an aldehyde dehydrogenase 23 , we hypothesized that it catalyzes dehydrogenation of 4-hydroxybenzaldehyde (4-HBz) to form 4-HB. Consistently, 4-HBz was elevated in ∆hfd1 yeast ( Supplementary Fig. 7b ).
P-value
We used chemical genetics to test the proposed Hfd1p activity. Most culture media contain either 4-HB (in yeast extract) or pABA (in standard yeast nitrogen base), enabling yeast to bypass the Tyr-to-4-HB pathway, so we used a defined medium lacking pABA and 4-HB (pABA − ). ∆hfd1 yeast exhibited striking respiration deficiency on pABA − media, a deficiency reversed by pABA, 4-HB, or WT Hfd1p, but not by Hfd1p with mutations to putative catalytic residues 24 ( Fig. 2d and Supplementary Fig. 7c-e ). Testing a panel of potential intermediates in the pathway revealed that 4-HB, but not 4-HBz, can restore the respiratory growth and CoQ production of ∆hfd1 yeast ( Fig. 2e,f and Supplementary Fig. 7f,g) , supporting a role for Hfd1p in dehydrogenation of 4-HBz. To directly test this activity, we purified recombinant Hfd1p for enzyme assays ( Supplementary  Fig. 7h ). WT Hfd1p catalyzes NAD + -dependent dehydrogenation of 4-HBz, but a C273S (catalytic residue) point mutant does not ( Fig. 2g) . Together, these results demonstrate that Hfd1p dehydrogenates 4-HBz to produce 4-HB for CoQ biosynthesis.
Hfd1p is a member of the ancient aldehyde dehydrogenase (ALDH) superfamily, which is found across all three superkingdoms of life and includes 19 human homologs with diverse functions 25 . Phylogenetic analyses showed Hfd1p to be most similar to the human ALDH3 family (Supplementary Fig. 7i ). ALDH3A2 (formerly called FALDH) mutations lead to Sjögren-Larsson syndrome 26 because they impede fatty aldehyde metabolism. However, the endogenous functions of ALDH3A1, ALDH3B1, and ALDH3B2 remain obscure, and which of these human ALDH3 functions are conserved in Hfd1p has not been completely defined. Previous work showed that sphingolipid metabolism is perturbed in ∆hfd1 yeast owing to a defect in dehydrogenation r e s o u r c e of hexadecanal, and that this defect can be reversed by ALDH3A2, but not by ALDH3A1 (refs. 23, 27) . However, a separate sphingolipid pathway defect (∆dpl1) did not disrupt the 4-HB-CoQ pathway ( Supplementary Fig. 7j-m and Supplementary Note 3) , suggesting that the two pathways are otherwise independent. Consistent with the idea that Hfd1p is a dual-function protein that supports both sphingolipid metabolism and CoQ biosynthesis, we observed Hfd1p activity in vitro with hexadecanal, similar to that observed with 4-HBz ( Fig. 2g) . However, in contrast to rescue of the sphingolipid metabolism defect, we found that ALDH3A1, but not ALDH3A2, rescued the pABA − respiratory growth phenotype of ∆hfd1 yeast ( Fig. 2h and Supplementary Fig. 7n ). Moreover, while ALDH3A2 showed a strong substrate preference for hexadecanal over 4-HBz, Hfd1p and ALDH3A1 showed a preference for 4-HBz ( Fig. 2i and Supplementary Fig. 7o-q) . These results suggest that the dual functions of yeast Hfd1p have diverged in human ALDH3A1 and ALDH3A2. Collectively, these results demonstrate a major cellular function for the aldehyde dehydrogenase Hfd1p in the Tyr-to-4-HB pathway and strongly suggest that ALDH3A1 plays a similar role in human CoQ biosynthesis.
Regression analysis of global perturbation profiles
While molecular changes unique to a given ∆gene strain can be functionally informative, similarities between ∆gene strains can also assist characterization. In our second analysis approach, we examined ∆gene-∆gene correlations through pairwise comparisons of global ∆gene perturbation profiles. Deletion of functionally related genes, such as the cytochrome c oxidase genes cox12 and cox23, caused highly similar whole proteome perturbations ( Fig. 3a) . Notably, highly correlated phenotype changes were also observed in ∆cox12 and ∆cox23 metabolomes and lipidomes ( Fig. 3a) . However, deletion of unrelated genes, such as cox12 and mic26, generated uncorrelated phenotype changes ( Fig. 3a) . Examination of ∆gene-∆gene correlations across the entire study indicated numerous functional relationships, with stronger correlations observed in respiration ( Fig. 3b) .
A group of respiration-deficient (RD) strains showed robust correlations across all three omes ( Fig. 3b) , reflecting their similar broad biological functions in mitochondrial oxidative phosphorylation and suggesting that they share a universal respiration deficiency response (RDR). Multi-omic principle component and GO term analyses revealed a coordinated RDR that provides biological insight into respiration log 2 (∆cox23/WT) r 2 = 0.93 log 2 (∆cox23/WT) r 2 = 0.9 log 2 (∆cox23/WT) log 2 (∆mic26/WT) 
∆ h e m 2 5 r e s o u r c e defects-a common feature of many diseases including cancer-and suggests that a multi-omic biomarker fingerprint could afford a specific diagnostic for mitochondrial disease ( Fig. 3c-f, Supplementary Fig. 8 , Supplementary Note 4, and Supplementary Table 5 ). However, stress responses such as the RDR also pose a barrier to biochemical investigations because they can obscure functionally informative phenotypes.
To assess more specific biochemical roles for individual proteins, we normalized for the RDR across RD strains ( Supplementary Fig. 9 and Supplementary Note 5). Across all of our RD strains, 776 molecules were identified as being consistently perturbed (Supplementary Table 6 ).
The individual measurements of these RDR-associated molecules were mean normalized (RDR-adjusted) to reveal characteristic deviations from the general RDR and to enable visualization of ∆gene-specific changes. Recalculating ∆gene-∆gene correlation coefficients with RDRadjusted plots strikingly reduced correlations between more functionally disparate genes ( Supplementary Fig. 9c-e and Supplementary  Table 7 ). Reclustering ∆gene-∆gene correlations revealed new clusters of genes with similar biochemical functions ( Fig. 3g) . For example, known CoQ biosynthesis genes were brought into a tighter cluster that also included the uncharacterized gene yjr120w (Fig. 3g) , suggesting that yjr120w might support CoQ biosynthesis. Consistently, we observed CoQ deficiency in ∆yjr120w yeast ( Fig. 3h) , the molecular basis of which we determined to include loss of Atp2p, an ATP synthase subunit ( Supplementary Fig. 10 and Supplementary Note 6).
These results show that specific ATP synthase subunits support CoQ biosynthesis and, more broadly, demonstrate how global MS profiling can reveal functional links between genes.
Molecule covariance network analysis
Similarly, in our third analysis approach, we leveraged the multi-omic nature of our MS profiles to determine pairwise covariance between proteins, metabolites, and lipids. This approach is similar to mRNA coexpression profiling, which can be used to predict gene function [28] [29] [30] , but it integrates three complementary classes of molecules.
Abundance changes of functionally related molecules, such as the protein Coq4p and the lipid CoQ intermediate PPHB, showed strong positive or negative correlations, while those of unrelated molecules, such as Coq4p and Rpb4p, did not ( Fig. 4a) . Correlated molecules included proteins in complexes, such as the cytosolic TRiC/CCT chaperonin complex (Cct2p and Cct7p), and enzyme-product pairs (e.g., Ura1p and orotic acid) ( Fig. 4a) .
Examining correlations across all 4,505 molecules in the Y3K data set through this multi-omic molecule covariance network analysis (MCNA) revealed numerous functional relationships, which can be visualized as networks of molecules (nodes) and correlations (edges) ( Fig. 4b, Supplementary Fig. 11a, and Supplementary Table 8 ). After applying strict correlation thresholds (Bonferroni-adjusted P-value < 0.001, |ρ| ≥ 0.58), 237,342 edges remained among 2,382 nodes in the respiration data set (Supplementary Fig. 11a-f) . Many edges were observed between RDR-associated molecules ( Supplementary  Fig. 11g) , reflecting their common relationship to mitochondrial metabolism. As described above for ∆gene correlations, we deepened the molecular insight of the MCNA by RDR adjustment, which reduced overall connectivity and increased the selectivity of functionally related molecule subnetworks (Supplementary Fig. 11g) .
For example, the selectivity of the mitochondrial ribosome subnetwork increased 16-fold (Supplementary Fig. 11h) . These RDR-adjusted networks associated the MXP Yor020w-a with the mitochondrial ribosome (Supplementary Fig. 11g) . To test this association, we examined the proteome of ∆yor020w-a yeast, which showed a significant (P < 0.05) decrease in the mitochondrial ribosome protein Rsm19p (Supplementary Fig. 11i ), suggesting that Yor020w-a is linked to mitochondrial translation.
Hundreds of additional uncharacterized proteins were linked to characterized molecules by our MCNA, providing a foundation for generating hypotheses about their functions ( Fig. 4b, Supplementary  Figs. 12 and 13) . For example, the MXP Aim18p was linked to a network of CoQ biosynthesis proteins, and Aro9p and Aro10p were linked to numerous mitochondrial proteins that support oxidative phosphorylation ( Fig. 4c-e ). Based on domain homology and predicted enzymatic functions, we hypothesized that Aim18p, Aro9p, and Aro10p could function in the Tyr-to-4-HB pathway ( Supplementary Fig. 14  and Supplementary Note 7) . Consistently, when cultured in a pABA − media, ∆aim18, ∆aro9, and ∆aro10 yeast are deficient in both CoQ and PPHB (Fig. 4f) . This work shows how global MS profiling can be used to generate biological hypotheses and characterize protein functions through distinct multi-omic data analysis approaches (Fig. 4g) . Figs. 12 and 13) 
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Ygr266w Ykr023w Ykr070w Ylr253w r e s o u r c e DISCUSSION A constant challenge in biology is to comprehensively monitor and understand the molecular effects of a defined alteration (e.g., a disease mutation, a drug treatment, or a gene deletion). Mass spectrometry (MS) has become central to answering this challenge.
Here, we leveraged a subset of our multi-omic data set to investigate gaps in knowledge of CoQ biosynthesis. Despite CoQ's essential function in the mitochondrial electron transport chain, role as a key cellular antioxidant, and its link to numerous human diseases (e.g., ataxias, myopathies, and nephrotic syndromes), multiple steps in CoQ biosynthesis remain uncharacterized 17, 31, 32 . In particular, enzymes involved in the initial stage of CoQ biosynthesis-wherein the headgroup precursor 4-HB is produced-were previously undefined in mammals and yeast.
Our ∆gene-specific phenotype detection approach suggested a role for the ancient aldehyde dehydrogenase superfamily member Hfd1p in 4-HB biosynthesis. Biochemical and genetic studies confirmed this role for Hfd1p in yeast and further demonstrated that the human homolog ALDH3A1 can also catalyze production of 4-HB in vivo and in vitro (Fig. 2) , thereby highlighting ALDH3A1 as a candidate disease gene for primary CoQ deficiency.
Distinct Y3K data set analyses placed additional proteins in the CoQ biosynthesis pathway. MCNA showed unexpected connections between Aro9p, Aro10p, and mitochondrial oxidative phosphorylation proteins, which helped place Aro9p and Aro10p in the Tyr-to-4-HB pathway (Fig. 4) . Similarly, links between Aim18p and known CoQ biosynthesis enzymes also connected Aim18p to CoQ biosynthesis. Furthermore, Y3K gene-gene correlation analyses and manual pathway analyses linked CoQ biosynthesis to other proteins whose molecular functions in this pathway are not yet fully defined (e.g., Atp2p, Fzo1p, and Oct1p). Disruption of the mammalian Fzo1p homolog, MFN2-a protein essential for mitochondrial fusion that harbors causative mutations in Charcot-Marie-Tooth disease 33 -was recently shown to cause CoQ deficiency through an unclear molecular mechanism 34 . Our results suggest that this unexpected relationship between MFN2 and CoQ biosynthesis is evolutionarily conserved, and establish yeast as a model system for further probing its mechanism.
Our Y3K data set provides many additional leads for further biochemical studies of numerous metabolic pathways that impact human health and disease, and we expect that the open access web utility (http://y3kproject.org/) will enable others to generate their own hypotheses. With demand for multi-omic data set analysis approaches increasing, we also hope that our multifaceted, data visualization website will serve as a useful model for future studies.
We anticipate that the multi-omic Y3K data set will provide a resource for broader systems biology inquiries. For example, our definition of the yeast respiration deficiency response (RDR) (Fig. 3 ) may assist studies of how cells broadly respond to defects in oxidative phosphorylation, which are observed in diverse diseases including many cancers. Our RDR work also suggests that a multiomic fingerprint of numerous molecules could provide a highly specific biomarker panel.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. Raw MS data files from all proteome, metabolome, and lipidome analyses are available through the CHORUS project data repository (Project ID 1119). All software used for GC/MS quantitation and data analysis is available online at Github (https://github.com/coongroup/ Y3K-Software) along with corresponding usage documentation.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.

ACKNoWLEDGMENTS
We thank members of the Pagliarini and Coon laboratories for helpful discussions. using MaxLFQ with a label-free quantification (LFQ) minimum ratio count of 2. LFQ intensities were calculated using the match between runs feature, and MS/MS spectra were not required for LFQ comparisons. Missing values were imputed where appropriate for proteins quantified in ≥50% of MS data files in a batch. Proteins not meeting this requirement were omitted from subsequent analyses. Imputation was performed on a replicate-by-replicate basis. For each replicate MS analysis a normal distribution with mean and s.d. equivalent to that of the lowest 1% of measured LFQ intensities was generated. Missing values were filled in with values drawn from this distribution at random. Approximately 4.05% and 4.53% of quantitative measurements were imputed in the respiration and fermentation proteomic data sets, respectively. Replicate protein LFQ values from corresponding ∆gene or WT strains were pooled, log 2 transformed, and averaged (mean log 2 [strain], n = 3). Average ∆gene LFQ intensities were normalized against their appropriate WT control (mean log 2 [∆gene/WT], n = 3) and a 2-tailed t-test (homostatic) was performed to obtain P values.
To control for batch-specific effects, proteins having unexpected and characteristic misregulation across a majority of ∆gene strains processed together were identified and omitted from the data set. For each protein quantified within a batch of ∆gene strains a distribution of protein foldchanges (intra-batch) was generated. The analogous distribution of protein fold-changes from all other ∆gene strains processed separately (inter-batch) was created. These two distributions were compared against each other using a Kolmogorov-Smirnov test (2-tailed) to obtain P values. If a significant difference existed at P < 0.05 (Bonferroni-adjusted) protein abundance measurements were omitted from the batch in question. This process of comparing intra-batch and inter-batch protein fold-change distributions was carried iteratively and to exhaustion and resulted in the omission of an average of 165 proteins/∆gene strain (~4.8% of quantified proteins) for respiration, and 188 proteins/∆gene strain (~5.9%) for fermentation.
LC-MS lipidomics. 1 × 10 8 yeast cells were harvested by centrifugation (3,000 g, 3 min, 4 °C), the supernatant was removed, and the cell pellet was flash frozen in N 2(l) and stored at −80 °C. Frozen yeast pellets (1 × 10 8 cells) were thawed on ice and mixed with glass beads (0.5 mm diameter, 100 µL). LC-MS analysis was performed on an Ascentis Express C18 column held at 35 °C (150 mm × 2.1 mm × 2.7 µm particle size; Supelco) using an Accela LC Pump (500 µL/min flow rate; Thermo). Mobile phase A consisted of 10 mM ammonium acetate in ACN/H 2 O (70:30, v/v) containing 250 µL/L acetic acid. Mobile phase B consisted of 10 mM ammonium acetate in IPA/ACN (90:10, v/v) with the same additives. Initially, mobile phase B was held at 50% for 1.5 min and then increased to 95% over 6.5 min where it was held for 2 min. The column was then reequilibrated for 3.5 min before the next injection. 10 µL of sample were injected by an HTC PAL autosampler (Thermo). The LC system was coupled to a Q Exactive mass spectrometer (Build 2.3 SP2) by a HESI II heated ESI source kept at 325 °C (Thermo). The inlet capillary was kept at 350 °C, sheath gas was set to 35 units, and auxiliary gas to 15 units, and the spray voltage was set to 3,000 V. Several scan functions were used to achieve optimal data acquisition for different lipid classes. For phospholipids, MS 1 (MS scan of precursor ions without fragmentation) data were acquired from 1-9 min at a resolving power of 35,000 with the AGC target set to 1 × 10 6 , mass range to 500-900 Th, and maximum injection time to 250 ms. For fatty acids and lyso species (lipids lacking a fatty acyl tail) MS 1 data were acquired from 0-3 min at a resolving power of 17,500 with the AGC target set to 5 × 10 5 , mass range to 220-600 Th, and maximum injection time to 100 ms. For cardiolipins, MS 1 data were acquired from 6.5-9.5 min at a resolving power of 17,500 with the AGC target set to 5 × 10 5 , mass range to 1320-1500 Th, and maximum injection time to 250 ms. For cytidine diacylglycerols, MS 1 data were acquired from 1-4.5 min at a resolving power of 17,500 with the AGC target set to 5 × 10 5 , mass range to 920-1050 Th, and maximum injection time to 250 ms. Quantitation for all of these species was performed by integrating the MS 1 
ONLINE METHODS
Yeast strains and cultures. The parental (WT) Saccharomyces cerevisiae strain for this study was the haploid MATalpha BY4742. Single gene deletion (∆gene) derivatives of BY4742 were either obtained through the gene deletion consortium 30 (Thermo #YSC1054) or made in-house using a KanMX deletion cassette to match those in the consortium collection. All gene deletions were confirmed by either proteomics (significant decrease in the encoded protein) or a PCR assay. ∆gene strains made in-house were also confirmed by gene sequencing.
Single lots of yeast extract ('Y') (Research Products International, RPI), peptone ('P') (RPI), agar (Fisher), dextrose ('D') (RPI), glycerol ('G') (RPI), and G418 (RPI) were used for all media. YP and YPG solutions were sterilized by automated autoclave. G418 and dextrose were sterilized by filtration (0.22 µm pore size, VWR) and added separately to sterile YP or YPG. YPD+G418 plates contained yeast extract (10 g/L), peptone (20 g/L), agar (15 g/L), dextrose (20 g/L), and G418 (200 mg/L). YPD media (fermentation cultures) contained yeast extract (10 g/L), peptone (20 g/L), and dextrose (20 g/L). YPGD media (respiration cultures) contained yeast extract (10 g/L), peptone (20 g/L), glycerol (30 g/L) and dextrose (1 g/L).
Yeast from a −80 °C glycerol stock were streaked onto YPD+G418 plates and incubated (30 °C, ~60 h) . Starter cultures (3 mL YPD) were inoculated with an individual colony of yeast and incubated (30 °C, 230 r.p.m., 10-15 h). A WT culture was included with each set of ∆gene strain cultures (usually 19 ∆gene cultures and 1 WT culture). Cell density was determined by optical density at 600 nm (OD 600 ) as described 35 . YPD or YPGD media (100 mL media at ambient temperature in a sterile 250 mL Erlenmeyer flask) was inoculated with 2.5 × 10 6 yeast cells and incubated (30 °C, 230 r.p.m.). Samples of the YPD cultures were harvested 12 h after inoculation, a time point that corresponds to early fermentation (logarithmic) growth. Samples of YPGD cultures were harvested 25 h after inoculation, a time point that corresponds to early respiration growth.
Liquid chromatography tandem mass spectrometry (LC-MS/MS) proteomics.
1 × 10 8 yeast cells were harvested by centrifugation (3,000 g, 3 min, 4 °C), the supernatant was removed, and the cell pellet was flash frozen in N 2(l) and stored at −80 °C. Yeast pellets were resuspended in 8 M urea, 100 mM tris (pH = 8.0). Yeast cells were lysed by the addition of methanol to 90%, followed by vortexing (~30 s). Proteins were precipitated by centrifugation (12,000 g, 5 min). The supernatant was discarded, and the resultant protein pellet was resuspended in 8 M urea, 10 mM tris(2-carboxyethyl)phosphine (TCEP), 40 mM chloroacetamide (CAA) and 100 mM tris (pH = 8.0). Sample was diluted to 1.5 M urea with 50 mM tris and digested with trypsin (Promega) (overnight, ~22 °C) (1:50, enzyme/protein). Samples were desalted using Strata X columns (Phenomenex Strata-X Polymeric Reversed Phase, 10 mg/mL). Strata X columns were equilibrated with one column volume of 100% acetonitrile (ACN), followed by 0.2% formic acid. Acidified samples were loaded on column, followed by washing with three column volumes of 0.2% formic acid or 0.1% trifluoroacetic acid (TFA). Peptides were eluted off the column by the addition of 500 µL 40% ACN with either 0.2% formic acid or 0.1% TFA and 500 µL 80% ACN with either 0.2% formic acid or 0.1% TFA. Peptide concentration was measured using a quantitative colorimetric peptide assay (Thermo). LC-MS/MS analyses were performed using previously described methodologies 1, 2 .
Data analysis. Raw data files were acquired in batches of 60 (3 biological replicates of 19 ∆gene strains and 1 WT strain) with time between LC-MS analyses minimized to reduce run-to-run variation. Batches of raw data files were subsequently processed using MaxQuant 36 (Version 1.5.0.25). Searches were performed against a target-decoy 37 database of reviewed yeast proteins plus isoforms (UniProt, downloaded January 20, 2013) using the Andromeda 38 search algorithm. Searches were performed using a precursor search tolerance of 4.5 p.p.m. and a product mass tolerance of 0.35 Da. Specified search parameters included fixed modification for carbamidomethylation of cysteine residues and a variable modification for the oxidation of methionine and protein N-terminal acetylation, and a maximum of two missed tryptic cleavages. A 1% peptide spectrum match (PSM) false discovery rate (FDR) and a 1% protein FDR was applied according to the target-decoy method. Proteins were identified using at least one peptide (razor + unique). Proteins were quantified demethoxycoenzyme Q 6 were monitored from 4.7 to 5.8 min by positive ion tandem mass spectrometry using the 591.44 → 197.08 Th and 561.43 → 167.07 Th transitions at a normalized collision energy of 27 units, a resolving power of 17,500, a maximum injection time of 250 ms, and an isolation width of 1.5 Th. For some follow-up studies MS 1 spectra were acquired from 200-1550 m/z supplemented with scheduled targeted scan modes to quantify key CoQ intermediates in their optimal polarity. Data analysis. Peaks were automatically integrated using TraceFinder software (Thermo) and all integrations were checked manually. Missing values from undetected peaks were imputed and imputation was performed on a replicate-by-replicate basis. For each replicate MS analysis a normal distribution with mean and s.d. equivalent to that of the lowest 5% of measured peak intensities was generated. Missing values were filled in with values drawn from this distribution at random. Approximately 1.03% and 0.85% of values were imputed in the respiration and fermentation lipidomic data sets, respectively. Total measured ion current from peaks quantified within replicate MS analyses was normalized to a corresponding WT control using a two-step procedure. First, to account for differences in cardiolipin extraction efficiency, summed cardiolipin intensities were normalized to equal the summed intensity of corresponding cardiolipin species in the WT control. All other lipid intensities were then normalized to equal the summed intensity of non-cardiolipin species in the same control. Replicate lipid intensities from corresponding ∆gene or WT strains were pooled, log 2 transformed, and averaged (mean log 2 [strain], n = 3). Mean intensities were then normalized to WT (mean log 2 [∆gene/WT], n = 3) and a 2-tailed t-test (homostatic) was performed to obtain P values.
Gas chromatography-mass spectrometry (GC-MS) metabolomics. 1 × 10 8 yeast cells yeast cells were isolated by rapid vacuum filtration onto a nylon filter membrane (0.45 µm pore size, Millipore) using a Glass Microanalysis Filter Holder (Millipore), briefly washed with phosphate buffered saline (1 mL), and immediately submerged into ACN/MeOH/H 2 O (2:2:1, v/v/v, 1.5 mL, pre-cooled to −20 °C) in a plastic tube. The time from sampling yeast from the culture to submersion in cold extraction solvent was less than 30 s. Tubes with the extraction solvent, nylon filter, and yeast were stored at −80 °C before analysis.
Tubes with yeast extract (also still containing insoluble yeast material and the nylon filter) were thawed at room temperature for 45 min., vortexed (~15 s), and centrifuged at room temperature (6,400 r.p.m., 30 s) to pellet insoluble yeast material. Yeast extract (25 µL aliquot) and internal standards (25 µL aqueous mixture of isotopically labeled alanine-2,3,3,3-d 4 , adipic acid-d 10 , and xylose-13 C 5 acid, 5 p.p.m. in each) were aliquoted into a 2 mL plastic tube and dried by vacuum centrifuge (~1 h). The dried metabolites were resuspended in pyridine (25 µL) and vortexed. 25 µL of N-methyl-N-trimethyl silyl]trifluoroacetamide (MSTFA) with 1% trimethylchlorosilane (TMCS) was added, and the sample was vortexed and incubated (60 °C, 30 min). Samples were then transferred to glass autosampler vials and analyzed using a GC-MS instrument comprising a Trace 1310 GC coupled to a Q Exactive Orbitrap mass spectrometer. For the yeast metabolite extracts a linear temperature gradient ranging from 50 °C to 320 °C was employed spanning a total runtime of 30 min. Analytes were injected onto a 30-m TraceGOLD TG-5SILMS column (Thermo) using a 1:10 split at a temperature of 275 °C and ionized using electron ionization (EI). The mass spectrometer was operated in full scan mode using a resolution of 30,000 (m/∆m) relative to 200 m/z. Data analysis. The resulting GC-MS data were processed using an in-housedeveloped software suite (https://github.com/coongroup/Y3K-Software). Briefly, all m/z peaks are aggregated into distinct chromatographic profiles (i.e., feature) using a 10 p.p.m. mass tolerance. These chromatographic profiles are then grouped according to common elution apex (i.e., feature group). The collection of features (i.e., m/z peaks) sharing a common elution apex, therefore, represent an individual electron ionization (EI)-MS spectrum of a single eluting compound. The EI-MS spectra were then compared against a matrix run and a background subtraction was performed. Remaining EI-MS spectra are then searched against the NIST 12 EI-MS library and subsequently subjected to a high-resolution filtering (HRF) technique as described elsewhere. EI-MS spectra that were not identified were assigned a numeric identifier. Feature intensity, which was normalized using total metabolite signal, was used to estimate metabolite abundance. Following initial processing, raw data files were re-analyzed to extract metabolite signals which were not successfully deconvolved and registered as missing values in the data set. This process provided measurements for ~1.87%, and 2.25% of metabolites quantified in the respiration and fermentation data sets, respectively. Remaining missing values were imputed using the same imputation strategy as described in the proteomic data processing section. Quantitative values imputed using this process account for ~0.17% and 0.13% of metabolites in the respiration and fermentation data sets, respectively.
Replicate metabolite intensities from corresponding ∆gene or WT strains were pooled, log 2 transformed, and averaged (mean log 2 [strain], n = 3). Average ∆gene metabolite intensities were normalized against their appropriate WT control (mean log 2 [∆gene/WT], n = 3) and a 2-tailed t-test was performed to obtain P values. To account for batch-specific effects the same Kolmogorov-Smirnov testing approach as described in the proteomic data processing section was used. Distributions of inter-batch and intra-batch metabolite fold changes were compared iteratively and those that were significantly different at P < 0.05 (Bonferroni-adjusted) resulted in metabolite abundance measurements being omitted from the batch in question (~15 metabolites/∆gene strain [~5.0%] from respiration and ~21 metabolites/∆gene strain [~5.9%] from fermentation).
Dgene-specific phenotype detection. For each profiled molecule (in both respiration and fermentation growth conditions) we separated potential ∆gene-specific measurements into two groups: positive log 2 fold change (log 2 [∆gene/WT]) and negative log 2 fold change. These two sets were then plotted individually with log 2 fold change and −log 10 (P-value [two-sided Student's t-test]) along the x and y axes, respectively. Data were normalized such that the largest log 2 fold change and largest −log 10 (P-value) were set equal to 1. Considering the three largest fold changes where P < 0.05, we calculated the Euclidean distance to all neighboring data points and stored the smallest result. A requirement was imposed that all considered 'neighbors' have a smaller fold change than the data point being considered. It is anticipated that data points corresponding to ∆gene-specific phenotypes will be outliers in the described plots and have large associated nearest-neighbor Euclidean distances. The described routine yielded three separate distances, the largest of which was stored for further analysis. We set a cutoff for classification as a '∆gene-specific phenotype' at a Euclidean distance of 0.70.
used and a minimum of 20 proteins was required. Correlations and clustering were otherwise conducted as described above.
Hierarchical clustering. All hierarchical clustering performed in this study was done in Perseus. For all clustering operations Spearman correlation was used with average linkage, preprocessing with k-means, and the number of desired clusters set to 300 for both rows and columns.
For clustering of ∆gene perturbation profiles, clustering was performed separately for fermentation and respiration data sets, and column-wise cluster order for fermentation and respiration data sets was generated using only protein fold change profiles. Column ordering was then applied to metabolite and lipid fold change data sets from the corresponding growth condition and row-wise clustering was conducted. GO term enrichment was performed in Perseus. P values were obtained from a Fisher's exact test, adjusted for multiple hypothesis testing 39 and reported where P < 0.05.
For the analysis of ∆gene-∆gene correlations, clustering was performed on respiration protein perturbation profile correlation data, and the resultant ordering was applied to ∆gene-∆gene correlation data sets from all other omes and growth conditions for parallel visual display. The same clustering process was carried out for the analysis of ∆gene-∆gene correlations of RD ∆gene strains following RDR adjustment.
